版本:
中国

Mallinckrodt Plc (MNK.N)

MNK.N ( 纽约证券交易所 )

16.06USD
04:31 BJT
涨跌 (%)

$0.14 (+0.88%)
收盘
$15.92
开盘
$16.07
当日最高
$16.75
当日最低
$16.04
成交量
314,635
平均成交量
737,782
52 周最高
$54.90
52 周最低
$15.29

Chart for

概况

Mallinckrodt public limited company负责开发、制造、营销和分销品牌和通用名特种药品与疗法。该公司从事多领域治疗,如自身免疫与罕见疾病专业领域(包括神经病学、风湿病学、肾脏学、眼科学和肺脏学)、免疫治疗与新生儿重症监护呼吸治疗、镇痛剂与止血产品和中枢神经系统药物。该公司的业务部门包括特种... (更多)

概况

Beta: 1.09
市值(百万): $1,512.48
已发行股本(百万): 95.00
股息: --
股息收益率 (%): --

财务指标

  Industry Sector
P/E (TTM): -- 30.98 16.31
EPS (TTM): -- -- --
ROI: -- 14.12 35.74
ROE: -- 15.72 17.71

BRIEF-Mallinckrodt Receives FDA Acceptance Of Stannsoporfin New Drug Application Filing

* MALLINCKRODT RECEIVES FDA ACCEPTANCE OF STANNSOPORFIN NEW DRUG APPLICATION FILING 全文
02/23 20:02

BRIEF-Paulson & Co Cuts Share Stake In Mallinckrodt PLC

* PAULSON & CO CUTS SHARE STAKE IN MALLINCKRODT PLC TO 3.7 MILLION SHARES FROM 6.6 MILLION SHARES - SEC FILING 全文
02/15 06:41

BRIEF-Mallinckrodt Enrolls First Patient In Phase 1 Study Of Skin Tissue

* MALLINCKRODT ENROLLS FIRST PATIENT IN PHASE 1 STUDY OF EXPRESSGRAFT™C9T1 SKIN TISSUE Source text for Eikon: Further company coverage: 全文
02/14 19:36

BRIEF-Mallinckrodt Says Units Entered A $600 Million Senior Secured Term Loan Facility

* MALLINCKRODT PLC SAYS ON FEB 13, IN CONNECTION WITH THE MERGER, UNITS OF CO ENTERED INTO A $600 MILLION SENIOR SECURED TERM LOAN FACILITY- SEC FILING 全文
02/13 23:46

BRIEF-First Patient Enrolled In Mallinckrodt Phase 4 Trial Of H.P. Acthar Gel For Pulmonary Sarcoidosis

* FIRST PATIENT ENROLLED IN MALLINCKRODT PHASE 4 TRIAL OF H.P. ACTHAR® GEL (REPOSITORY CORTICOTROPIN INJECTION) FOR PULMONARY SARCOIDOSIS Source text for Eikon: Further company coverage: 全文
01/31 06:04

BRIEF-Mallinckrodt Will Sell Recothrom, Preveleak To Baxter for $185 Mln

* MALLINCKRODT - TOTAL DEAL CONSIDERATION OF $185 MILLION, WITH $153 MILLION UPFRONT, INCLUDING EXISTING INVENTORY, REMAINDER IN POTENTIAL MILESTONE PAYMENTS 全文
01/08 20:51

BRIEF-Baxter To Acquire Recothrom, Preveleak For Upfront Payment Of About $153 Mln

* BAXTER ANNOUNCES AGREEMENT TO BROADEN PORTFOLIO OF INNOVATIVE SURGICAL PRODUCTS 全文
01/08 20:49

BRIEF-Mallinckrodt Unit Borrowed $900 Mln Under Revolving Credit Facility

* MALLINCKRODT PLC SAYS ON DEC 29 UNIT OF CO BORROWED $900 MILLION AS A REVOLVING LOAN UNDER THE REVOLVING CREDIT FACILITY -SEC FILING 全文
01/05 20:08

BRIEF-Mallinckrodt Completes Stannsoporfin New Drug Application Filing

* MALLINCKRODT COMPLETES STANNSOPORFIN NEW DRUG APPLICATION FILING Source text for Eikon: Further company coverage: 全文
01/05 05:52

制药商Mallinckrodt出价约8.4亿美元收购同业Sucampo

路透12月26日 - 制药商Mallinckrodt 周二称,将以约8.4亿美元的价格收购Sucampo Pharmaceuticals,不包括债务,以获取其治便秘药物Amitiza。 全文
12/27 10:09

竞争者

  现值 涨跌额
Meda AB (MEDAa.ST) -- --
Merck KGaA (MRCG.DE) €82.34 -0.04
AB Science SA (ABS.PA) €8.10 -0.07

收益 vs. 预测